Management of Immunotherapy-Related Toxicity Panel - Disclosures
|
Panel Member
|
Amaka Achufusi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Philippe Armand MD, PhD |
|
Grant/Research Support
|
| Adaptive Biotechnologies | AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | Genentech, Inc. | IGM Biosciences | Kite Pharma | Merck & Co., Inc. |
|
Officer, Director or any other fiduciary role
|
| Tessa Therapeutics |
|
Date Completed
|
07/31/2024 |
|
Panel Member
|
Ajibola Awotiwon MBBS, MSc |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Meghan Berkenstock MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bonnie Bermas MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tawnie Braaten MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Julie Brahmer MD, MSc |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Bristol Myers Squibb | RAPT therapeutics |
|
Date Completed
|
06/06/2024 |
|
Panel Member
|
Elizabeth Lihua Budde MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Saurin Chokshi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Zachary Crees MD |
|
Grant/Research Support
|
| Gamida Cell |
|
Date Completed
|
03/19/2025 |
|
Panel Member
|
Marianne Davies DNP, RN, ACNP-BC, AOCNP, CNS, FAAN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Changchun Deng MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Yaron Gesthalter MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Diane Gray |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lisa Hang PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Prantesh Jain MD, FACP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michael Jain MD, PhD |
|
Grant/Research Support
|
| Eli Lilly and Company | Incyte Corporation | Kite Pharma |
|
Date Completed
|
01/24/2025 |
|
Panel Member
|
Andrew Jallouk MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Benjamin Kaffenberger MD, MS |
|
Grant/Research Support
|
| Biogen Idec | Bristol Myers Squibb | InflaRx | Merck & Co., Inc. |
|
Date Completed
|
10/16/2024 |
|
Panel Member
|
Ann Karosas RPh, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Maya Khalil MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Melissa Lechner MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tianhong Li MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Megan Lyons MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Alissa Marr MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Suzanne McGettigan MSN, CRNP, AOCN |
|
Product/Speakers Bureau
|
| Bristol Myers Squibb | Merck & Co., Inc. | Pfizer Inc. | Regeneron Pharmactcls |
|
Date Completed
|
02/10/2025 |
|
Panel Member
|
Jordan McPherson PharmD, MS, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Theresa Medina MD |
|
Grant/Research Support
|
| Anaveon | Bristol Myers Squibb | Day One Biopharmaceutical | Genentech, Inc. | Ideaya | Immunocore | Merck & Co., Inc. | Moderna | Pfizer Inc. | Regeneron Pharmactcls | Replimune | TriSalus | Ultimovacs |
|
Date Completed
|
11/13/2024 |
|
Panel Member
|
Nisha Mohindra MD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP |
|
Date Completed
|
04/24/2025 |
|
Panel Member
|
Anthony Olszanski MD, RPh |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sandip Patel MD |
|
Grant/Research Support
|
| Amgen, AstraZeneca, BeiGene, Bristol-Myers Squibb, Certis, Eli Lilly, Jazz, Genentech, Illumina , Merck, Pfizer, Signatera, Tempus |
|
Date Completed
|
01/26/2025 |
|
Panel Member
|
Jason Prosek MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sunil Reddy MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Pankti Reid MD, MPH |
|
Product/Speakers Bureau
|
| Amgen Inc. |
|
Date Completed
|
07/19/2024 |
|
Panel Member
|
Mabel Ryder MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Huda Salman MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bianca Santomasso MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bryan Schneider MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Scott Shofer MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Vidic |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Amanda Visnick BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Yinghong Wang MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vlad Zaha MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stephen Zucker MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
